Penny-wise, pound-foolish: the costs of cost-related medication restriction.
作者信息
Bierman Arlene S, Bell Chaim M
出版信息
Med Care. 2004 Jul;42(7):623-5. doi: 10.1097/01.mlr.0000131744.89372.b2.
Abstract
摘要
相似文献
1
Penny-wise, pound-foolish: the costs of cost-related medication restriction.小事聪明，大事糊涂：与费用相关的药物限制的代价。
Med Care. 2004 Jul;42(7):623-5. doi: 10.1097/01.mlr.0000131744.89372.b2.
2
Problems due to medication costs among VA and non-VA patients with chronic illnesses.退伍军人事务部（VA）和非退伍军人事务部慢性病患者中因药物费用产生的问题。
Am J Manag Care. 2004 Nov;10(11 Pt 2):861-8.
3
The health effects of restricting prescription medication use because of cost.因费用问题限制处方药使用对健康的影响。
Med Care. 2004 Jul;42(7):626-34. doi: 10.1097/01.mlr.0000129352.36733.cc.
4
Medication costs, adherence, and health outcomes among Medicare beneficiaries.医疗保险受益人的药物成本、依从性和健康结果。
Health Aff (Millwood). 2003 Jul-Aug;22(4):220-9. doi: 10.1377/hlthaff.22.4.220.
5
Chronic conditions and disabilities: trends and issues for private drug plans.慢性病与残疾：私人药品计划的趋势与问题
Policy Brief Commonw Fund. 2003 Oct(680):1-10.
6
McClellan says CMS will protect duals ... but others express doubts.麦克莱伦表示医疗保险和医疗补助服务中心将保护双重资格者……但其他人对此表示怀疑。
Med Health. 2005 Mar 7;59(9):3-4.
7
An Rx for reform: a Medicare prescription drug benefit.改革良方：医疗保险处方药福利
Health Matrix Clevel. 2002 Summer;12(2):449-505.
8
Pharmacy costs: your home state may help out.药品费用：你所在的州可能会提供帮助。
US News World Rep. 2000 Dec 11;129(23):84-5.
9
Hospitals given incentives to improve access to costly care.医院获得激励措施以改善昂贵医疗服务的可及性。
Health Care Strateg Manage. 2003 Dec;21(12):11.
10
Medicare drugs.医疗保险药物
Health Care Financ Rev. 2003 Winter;25(2):1-5.
引用本文的文献
1
Universal drug coverage and socioeconomic disparities in major diabetes outcomes.全民药物覆盖和主要糖尿病结局的社会经济差异。
Diabetes Care. 2012 Nov;35(11):2257-64. doi: 10.2337/dc12-0364. Epub 2012 Aug 13.
2
Was there compression of disability for older Americans from 1992 to 2003?1992年至2003年期间，美国老年人是否存在残疾压缩现象？
Demography. 2007 Aug;44(3):479-95. doi: 10.1353/dem.2007.0022.
Zotero 插件